Skip to main content
. 2015 Apr 9;9(4):e0003692. doi: 10.1371/journal.pntd.0003692

Fig 8. Ad-EVVLP but not FI-EV71 protects hSCARB2-Tg mice from CVA16 challenge.

Fig 8

One-day-old hSCARB2-Tg mice were pre-immunized twice s.c. with (A) PBS (●), 3 × 107 pfu Ad-LacZ (■), or 3 × 107 (▲) pfu Ad-EVVLP, or (B) 1 μg FI-EV71 vaccine (●) on Days 1 and 7 after birth prior to being challenged s.c. with 5 × 105 pfu CVA16. The survival of mice was monitored on a daily basis for 15 days. The number (N) of transgenic mice was shown. A log-rank test was used for statistical analysis.